Related Experiment Video
Updated: Feb 17, 2026
05:47
Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
1.6K
Evidence-Based Medicine and Rare Diseases
1Clinical Trials Consulting & Training Limited, 53 Portway, North Marston, Buckinghamshire, MK18 3PL, UK. simon.day@CTCT-Ltd.co.uk.
Advances in Experimental Medicine and Biology
|December 8, 2017
Summary
Evidence-based medicine relies on high-quality evidence, not solely randomized controlled trials. Understanding risks and evidence is crucial for informed patient and healthcare professional decision-making.
Area of Science:
- Medical Research Methodology
- Clinical Evidence Evaluation
- Healthcare Decision-Making
Background:
- High failure rates in drug development underscore the need for robust evidence.
- Unlicensed treatments, despite good intentions, pose risks due to limited testing.
- Patient and healthcare provider vulnerability to poor decisions stems from risk misunderstanding.
Purpose of the Study:
- To define evidence-based medicine and its relationship with randomized controlled trials.
- To explore various forms of reliable evidence beyond clinical trials.
- To emphasize the importance of informed decision-making for all stakeholders.
Main Methods:
- Discussion of evidence-based medicine principles.
- Analysis of drug development failure rates.
- Exploration of alternative evidence sources, including meta-analyses.
- Examination of patient choice and risk perception challenges.
Main Results:
- Evidence-based medicine encompasses more than just randomized controlled trials.
- Meta-analyses can address challenges in rare disease clinical trials.
- Informed decision-making requires guidance through complex evidence.
Conclusions:
- High-quality evidence is paramount for effective medical practice.
- Randomized controlled trials are valuable but not the sole source of evidence.
- Improved understanding and guidance are essential for navigating medical evidence and making sound choices.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:02Prescription, Nonprescription and Orphan Drugs
1.3K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.3K
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
168
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
168
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:29Pharmacogenomics: Identification of New Drug Targets
10
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
10
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
20
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
20